The FDA Approved HIV ‐1 Protease Inhibitors for Treatment of HIV / AIDS-Reference-Cited by-同舟云学术

The FDA Approved HIV ‐1 Protease Inhibitors for Treatment of HIV / AIDS

Published:2010-08-27 Issue: Volume: Page:1-74
ISSN:
Container-title:Burger's Medicinal Chemistry and Drug Discovery
language:
Short-container-title:

Author:

Ghosh Arun K.,Anderson David D.,Mitsuya Hiroaki

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/0471266949.bmc224

Reference217 articles.

1. UNAIDS Report on the global HIV/AIDS epidemic 2008. Available athttp//wwwunaidsorg/en/KnowledgeCentre/HIVData/GlobalReport/2008/2008_Global_report.asp. Accessed 2008 Oct 30.

2. Resistance to HIV protease inhibitors

3. Antiretroviral Drug Resistance Testing in Adults With HIV Infection

4. Drug Interactions of HIV Protease Inhibitors

5. Retroviral proteases: structure, function and inhibition from a non‐anticipated viral enzyme to the target of a most promising HIV therapy;der Helm K.;Biol Chem,1996

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Design, synthesis, and biological evaluation of novel HIV-1 protease inhibitors containing pyrrolidine-derived P2 ligands to combat drug-resistant variant;European Journal of Medicinal Chemistry;2023-07

2. Structures and energetics of darunavir and active site amino acids of native and mutant HIV–1 protease: a computational study;Structural Chemistry;2021-11-08

3. Design, Synthesis, and X-ray Studies of Potent HIV-1 Protease Inhibitors with P2-Carboxamide Functionalities;ACS Medicinal Chemistry Letters;2020-03-03

4. The Design, Development, and Evaluation of BACE1 Inhibitors for the Treatment of Alzheimer’s Disease;Topics in Medicinal Chemistry;2016

5. Tetrahydrofuran, tetrahydropyran, triazoles and related heterocyclic derivatives as HIV protease inhibitors;Future Medicinal Chemistry;2011-07